Placenta-mediated pregnancy complications are clinically important conditions and include
preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss …

Background Hypercoagulability and endothelial dysfunction are hallmarks of coronavirus
disease 2019 (COVID‐19) and appear to predict disease severity. A high incidence of …

A State of the Art lecture,“VTE Risk Assessment in Pregnancy,” was presented at the ISTH
congress in Melbourne, Australia, in 2019. Venous thromboembolism (VTE) remains a …

Venous thromboembolism (VTE) is still reported as the leading cause of direct maternal
death in pregnancy in serial international reports in developed countries. VTE risk is higher …

As the novel coronavirus disease sweeps across the world, there is growing speculation on
the role that atmospheric factors may have played on the different distribution of SARS-CoV …

Abstract Introduction Tissue Factor Pathway Inhibitor (TFPI) is a part of the extrinsic
coagulation pathway, and highly expressed in the placenta. We aimed to assess its potential …

Preeclampsia complicates up to 8% of pregnancies and is a leading cause of fetomaternal
morbidity andmortality. Treatment options are limited, with supportive care and delivery of …

Aim We aimed to explore a new approach and theoretical basis for the diagnosis, treatment
and prognosis of pre‐eclampsia. Methods In total, 103 pre‐eclamptic patients (study group …

Background Activation of the coagulation system and increased thrombin generation have
been implicated in the pathophysiology of preeclampsia, and this rationale supports the …

Venous thromboembolism (VTE) remains the leading cause of maternal mortality in
pregnancy and the postpartum period. In addition to the higher pregnancy-associated …